Originally based in Italy, Roboze plans to expand its American headquarters in Houston. Photo courtesy of Roboze

An innovative 3D printing manufacturer is moving in on the Bayou City — and is bringing with it a need for tens of new hires.

Roboze, based in southern Italy, is launching its American headquarters in Houston. The company plans to hire up to 25 people by the end of this year and more than 50 in the next year.

Originally based in Bari, Roboze's innovative 3D printing technology is set to land in Houston in September, with more than 20 industrial 3D printers, in order to form a stronger bond with local oil and gas companies who are their clients.

"Our 3D printers and supermaterials are used to produce end-use parts and small-medium series for production purposes, replacing obsolete production methods and replacing metals," says founder and CEO Alessio Lorusso in an email to InnovationMap.

The innovative technology is used to produce strong and super-resistant end-use parts that can be used in a variety of applications including oil and gas, aerospace, electric vehicles, and defense. The 3D printing technology is already being used by major industry leaders such as Sony, Bosch, Airbus, and the U.S. Army.

"The Houston along with the Texas market is especially interesting because of oil and gas," says Ilaria Guicciardini, marketing director for Roboze. "We are very involved in the oil and gas and aerospace sectors which are areas Houston excels in. The goal is to expand our brand and be closer to the customer which can only be done by expanding into the Houston area."

The 3D printing technology uses patented systems to provide precise and repeatable printing tech that optimizes production by supplying components, reducing the post-production process, and in turn warehousing and logistics costs.

Roboze has 300 printing machines around 24 countries around the world, with its Houston headquarters inauguration in September it will become the third largest printing facility in the local area. The facilities will be able to print benchmarks and parts for all of the 3D printing company's American customers, especially oil and gas clients in the Houston area.

"We want to invest in the U.S.," says Guicciardini. "We want to create our own team to invest in customer care for our American customers."Roboze's American headquarters will be located at 7934 Breen Drive Houston, Texas 77064, in Northwest Houston. The innovative 3D printing company's American operations will be led by Shirley Rivera, the U.S. Operations Manager at Roboze, a U.S. native with extensive experience in management roles in Italy.

"We are hoping to invest and reply to the demand for 3D printing for this kind of materials with the way we do at Roboze," says Guicciardini.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.